Catalyst Pharmaceutical Partne - CPRX - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 26, 2013

Catalyst Pharmaceutical Partne - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
CPRX	Nasdaq	2834	http://www.catalystpharma.com/	0.8799 +0.0449
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Catalyst Pharmaceutical Partne CATALYST PHARMACEUTICAL PARTNERS, INC. Financials - May 21st, 2013 11:04 am Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill - May 20th, 2013 9:30 am Catalyst Pharmaceutical Partners Reports First Quarter 2013 Financial Results - May 16th, 2013 6:03 am CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits - May 15th, 2013 11:26 pm Dr. Reddy's Earnings Increase Y/Y - May 15th, 2013 9:40 am FDA Accepts Merck BLA - May 15th, 2013 9:10 am CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report - May 15th, 2013 7:20 am Forest-Trevena Ink Deal - May 14th, 2013 9:10 am Jazz Pharma Posts Higher Y/Y Earnings - May 14th, 2013 8:20 am Salix Beats on Earnings - May 14th, 2013 7:45 am Narrower-than-Expected Loss at Supernus - May 14th, 2013 7:40 am Glaxo/THRX's Breo Ellipta Gets FDA Nod - May 13th, 2013 3:20 pm Wider-Than-Expected Loss at Anacor - May 13th, 2013 1:45 pm Pacira Reports Wider Loss - May 10th, 2013 7:15 am Wider-than-Expected Loss at Avanir - May 9th, 2013 7:10 am Santarus Beats on Earnings and Revs - May 8th, 2013 2:30 pm Ariad Posts Wider Y/Y Loss - May 8th, 2013 8:15 am Positive Data on Forest Combo Drug - May 7th, 2013 1:30 pm OncoGenex Loss Lower than Expected - May 6th, 2013 12:45 pm Wider-than-Expected Loss at Endocyte - May 6th, 2013 11:35 am View All Current Headlines >>